Prostatis Group’s FT Vest Rising Dividend Achievers Target Income ETF RDVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.72M Sell
126,488
-14,103
-10% -$389K 0.87% 32
2026
Q1
$3.59M Sell
140,591
-2,228
-2% -$59.6K 0.92% 31
2025
Q4
$3.75M Sell
142,819
-6,048
-4% -$157K 0.89% 35
2025
Q3
$3.85M Sell
148,867
-12,357
-8% -$312K 0.96% 26
2025
Q2
$3.98M Buy
161,224
+16,325
+11% +$384K 1.14% 23
2025
Q1
$3.44M Buy
144,899
+5,453
+4% +$135K 1.08% 21
2024
Q4
$3.38M Buy
139,446
+18,248
+15% +$459K 0.99% 26
2024
Q3
$2.99M Buy
121,198
+13,779
+13% +$331K 0.98% 31
2024
Q2
$2.51M Buy
107,419
+19,218
+22% +$454K 0.88% 36
2024
Q1
$2.16M Buy
+88,201
New +$2.04M 0.82% 35

Other funds holding RDVI

Prostatis Group's RDVI Position: Q2 2026 in Review

Prostatis Group reduced its FT Vest Rising Dividend Achievers Target Income ETF (RDVI) stake by 10% in Q2 2026, selling an estimated $389K and leaving 126,488 shares worth $3.72M. The position accounts for 0.87% of the portfolio, ranked #32.

Prostatis Group first reported a position in RDVI in Q1 2024 and has held it in 10 quarters since. The position peaked at $3.98M in Q2 2025. 313 funds tracked by Wall St. Rank hold RDVI as of Q2 2026.

  • Prostatis Group held 126,488 shares of FT Vest Rising Dividend Achievers Target Income ETF worth $3.72M as of Q2 2026.
  • Prostatis Group sold 14,103 FT Vest Rising Dividend Achievers Target Income ETF shares in Q2 2026, an estimated $389K.
  • FT Vest Rising Dividend Achievers Target Income ETF made up 0.87% of Prostatis Group's portfolio in Q2 2026, its #32 holding.
  • Prostatis Group first reported a position in FT Vest Rising Dividend Achievers Target Income ETF in Q1 2024 and has held it in 10 quarters since.
  • Prostatis Group's FT Vest Rising Dividend Achievers Target Income ETF position peaked at $3.98M in Q2 2025.
  • 313 funds tracked by Wall St. Rank held FT Vest Rising Dividend Achievers Target Income ETF as of Q2 2026.

Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.